Search
for

    Learn

    5 / 801 results

      learn Adenosine

      nucleoside used for hair regrowth stimulant properties

      learn Exosomes

      Microscopic delivery system that sends growth-promoting signals to hair follicles

      learn Valproic acid

      an anticonvulsant repurposed for hair loss via histone inhibition

      learn Bimatoprost

      a synthetic prostamide used to treat eyelashes also shows promise for stimulating hair growth on scalp

      learn Dexpanthenol

      precursor of vitamin B5 with hair stimulating effects

    Research

    5 / 1000+ results

    Community Join

    5 / 603 results

      community Oral 1mg Fin/ 2.5mg Min (Before/After)

      in Progress Pictures  127 upvotes 1 month ago
      The conversation discusses hair loss treatments, specifically the transition from topical to oral minoxidil and finasteride, and the associated shedding phase. Users advise patience and consistency, noting that shedding is common and improvement may take several months.

      community Transition from Baby Hair to Normal Hair?

      in Finasteride/Dutasteride  33 upvotes 1 year ago
      The conversation discusses the slow transition from baby hair to normal hair while using finasteride and transitioning to dutasteride, with progress except for the crown area. It's mentioned that hair thickening can take years, with each growth cycle potentially making the hair thicker, and this process can span over 6 months or more.

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  445 upvotes 3 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

      community Pyrilutamide Phase 3 on its way

      in Treatment  126 upvotes 4 years ago
      Pyrilutamide Phase 3 approved, starting early 2022 with 416 subjects for 24 weeks. Drug potentially better than RU and Breezula, with some users reporting no side effects.